SCHEMBL7478667

SCHEMBL7478667

CCc1nc(-c2ccc(N(C)C)cc2Cl)c(CC)nc1NC(C)CCOC

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6074947 0.87 CRHR1 (0.67) CRHR1
SCHEMBL6075119 0.85 CRHR1 (0.70) CRHR1
SCHEMBL6075122 0.83 CRHR1 (0.53) CRHR1
SCHEMBL6075508 0.80 CRHR1 (0.56) CRHR1
SCHEMBL5411684 0.76 CRHR1 (1.00) CRHR1
SCHEMBL7474926 0.76 CRHR1 (0.54) CRHR1
SCHEMBL6074971 0.74 CRHR1 (0.80) CRHR1
SCHEMBL5411811 0.73 CRHR1 (1.00) CRHR1
SCHEMBL6168500 0.71 CRHR1 (0.47) CRHR1
SCHEMBL6075376 0.71 CRHR1 (0.66) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed